Genprex Inc

General ticker "GNPX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $3.6M

Genprex Inc does not follow the US Stock Market performance with the rate: -34.2%.

Estimated limits based on current volatility of 7.0%: low 0.84$, high 0.97$

Factors to consider:

  • Current price 62.9% below estimated low
  • Earnings for 9 months up through Q3 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [2.52$, 10.40$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.28$, 5.04$]

Financial Metrics affecting the GNPX estimates:

  • Negative: Non-GAAP EPS, $ of -12.80 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -66.73 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
  • Positive: Interest expense per share, $ of 0 <= 0

Similar symbols

Short-term GNPX quotes

Long-term GNPX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $20.67MM $23.83MM $31.08MM
Operating Income $-20.67MM $-23.83MM $-31.08MM
Non-Operating Income $0.01MM $0.09MM $0.22MM
R&D Expense $8.61MM $11.51MM $17.62MM
Income(Loss) $-20.66MM $-23.74MM $-30.86MM
Profit(Loss) $-20.66MM $-23.74MM $-30.86MM
Stockholders Equity $41.28MM $22.27MM $7.42MM
Assets $42.86MM $25.09MM $10.67MM
Operating Cash Flow $-14.28MM $-17.78MM $-24.74MM
Capital expenditure $0.08MM $0.06MM $0.07MM
Investing Cash Flow $-0.08MM $0.10MM $-0.07MM
Financing Cash Flow $25.68MM $0.01MM $10.59MM
Earnings Per Share* $-16.64 $-24.59 $-22.58

* EPS are Split Adjusted, recent splits may be reflected with a delay.